GlassScriptPhysician profile
Caroline Watson
NPI 1144756875
$292,308.44
in general payments reported to CMS, 2019-2025
26 companies · $136K in 2025
The $136K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2021: $4,890 · 2022: $39K · 2023: $48K · 2024: $64K · 2025: $136K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $131K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $73K · Travel and Lodging: $24K · Food and Beverage: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,650 · Long Term Medical Supply Or Device Loan: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $130,591.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,531.00 |
| Travel and Lodging | $24,243.20 |
| Food and Beverage | $11,999.64 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,650.00 |
| Long Term Medical Supply Or Device Loan | $1,356.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $90,483.01 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $42,295.72 | 2022-2025 | Envista Mx60 Iol, Stellaris Elite, Crystalens Accommodating Iol (At-52ao) |
| Johnson & Johnson Surgical Vision, INC. | $39,955.83 | 2021-2025 | Ifs Advanced Femtosec Laser, Tecnis Simplicity, Veritas Vision System |
| Alcon Vision LLC | $30,351.38 | 2021-2025 | Ngenuity, Acrysof Iq Panoptix Uv Iol, Clareon |
| Biotissue Holdings INC. | $28,354.64 | 2022-2025 | |
| Dompe US, INC. | $16,760.92 | 2022-2024 | Oxervate |
| Alcon Research LLC | $11,062.50 | 2022-2024 | Ngenuity |
| Rxsight INC | $8,360.62 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Sight Sciences, INC. | $6,272.22 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument, Tearcare System |
| Beaver-Visitec International, INC. | $3,505.31 | 2022-2023 | |
| Carl Zeiss Meditec, INC. | $2,987.77 | 2022-2023 | Visumax, Veracity Surgical |
| Carl Zeiss Meditec USA, INC. | $2,343.96 | 2022-2025 | Visumax, Cirrus Hd-Oct, Veracity Surgical |
| Lensar, INC. | $2,227.30 | 2021-2025 | Lensar Laser System |
| Nordic Pharma, INC. | $2,100.00 | 2025 | Lacrifill |
| Abbvie INC. | $1,570.43 | 2023-2025 | Vuity |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $1,289.24 | 2023-2024 | Omidria, Rayone Aspheric, Rayone Spheric |
| Glaukos Corporation | $769.50 | 2021-2025 | Idosetr, Idose |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $409.25 | 2021 | |
| New World Medical,INC. | $353.38 | 2022-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Lumenis Be INC | $321.46 | 2025 | M22 |
| Ivantis, INC | $248.81 | 2021 | |
| Sun Pharmaceutical Industries INC. | $141.96 | 2023-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $55.95 | 2023 | Tecnis Simplicity |
| Tearlab Corp | $55.33 | 2023 | Tearlab Osmolarity System |
| Eyevance Pharmaceuticals LLC | $21.45 | 2022 | |
| Iridex Corporation | $10.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9.35 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.